Stay updated on Talacotuzumab vs. Daratumumab in MDS Clinical Trial

Sign up to get notified when there's something new on the Talacotuzumab vs. Daratumumab in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talacotuzumab vs. Daratumumab in MDS Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T08:40:19.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 with no substantive changes to trial details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T00:50:55.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision from v3.4.0 to v3.4.1 occurred with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T14:28:05.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    UI changes include the addition of Show glossary and Hide glossary options and capitalization tweaks to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new Revision: v3.4.0 label. There are no changes to core study content, eligibility criteria, or data presented on the page.
    Difference
    0.3%
    Check dated 2026-01-23T10:20:27.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no user-facing content or functionality appears to be changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T05:48:09.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Locations section consolidated and updated. Added Missouri, Pennsylvania, and Texas to the Locations list; separate Missouri Locations, Pennsylvania Locations, and Texas Locations sections were removed (Revision: v3.3.3).
    Difference
    0.4%
    Check dated 2025-12-25T15:55:15.000Z thumbnail image

Stay in the know with updates to Talacotuzumab vs. Daratumumab in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talacotuzumab vs. Daratumumab in MDS Clinical Trial page.